Krishnan Viswanadhan
Director/Board Member bei CARGO THERAPEUTICS, INC.
Vermögen: - $ am 31.03.2024
Profil
Krishnan Viswanadhan is currently the Director at JW Therapeutics (Shanghai) Co., Ltd.
He is also an Independent Non-Executive Director at JW (Cayman) Therapeutics Co. Ltd., an Independent Director at Cargo Therapeutics, Inc., and the President & Chief Operating Officer at Be Biopharma, Inc. Previously, he worked as the Vice President-Business Development at Celgene Corp.
and as a Program Manager at F.
Hoffmann-La Roche Ltd.
Dr. Viswanadhan holds an undergraduate and doctorate degree from Rutgers State University of New Jersey and an MBA from Cornell University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CARGO THERAPEUTICS, INC.
-.--% | 10.11.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Krishnan Viswanadhan
| Unternehmen | Position | Beginn |
|---|---|---|
| CARGO THERAPEUTICS, INC. | Director/Board Member | 01.10.2022 |
| JW (CAYMAN) THERAPEUTICS CO. LTD | Director/Board Member | 20.11.2019 |
JW Therapeutics (Shanghai) Co., Ltd.
 JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology JW Therapeutics (Shanghai) Co., Ltd. engages in biopharmaceutical industry. It focuses on the development, transformation, and promotion of cell-based immunotherapies to treat cancer. The company was founded by Yi Ping Li on February 18, 2016 and is headquartered in Shanghai, China. | Director/Board Member | - |
Be Biopharma, Inc.
 Be Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Be Biopharma, Inc. develops engineered B cells as a new category of cellular medicines. The company was founded by David Steinberg, Aleks Radovic-Moreno and Lea Hachigian and is headquartered in Cambridge, MA. | President | 01.07.2021 |
Ehemalige bekannte Positionen von Krishnan Viswanadhan
| Unternehmen | Position | Ende |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 01.08.2019 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Ausbildung von Krishnan Viswanadhan
| Rutgers State University of New Jersey | Doctorate Degree |
| Cornell University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| JW (CAYMAN) THERAPEUTICS CO. LTD | Health Technology |
| CARGO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology JW Therapeutics (Shanghai) Co., Ltd. engages in biopharmaceutical industry. It focuses on the development, transformation, and promotion of cell-based immunotherapies to treat cancer. The company was founded by Yi Ping Li on February 18, 2016 and is headquartered in Shanghai, China. | Health Technology |
Be Biopharma, Inc.
Be Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Be Biopharma, Inc. develops engineered B cells as a new category of cellular medicines. The company was founded by David Steinberg, Aleks Radovic-Moreno and Lea Hachigian and is headquartered in Cambridge, MA. | Commercial Services |
